Minh Lê

2.7k total citations
53 papers, 644 citations indexed

About

Minh Lê is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Minh Lê has authored 53 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Infectious Diseases, 23 papers in Virology and 13 papers in Epidemiology. Recurrent topics in Minh Lê's work include HIV/AIDS drug development and treatment (33 papers), HIV Research and Treatment (23 papers) and HIV/AIDS Research and Interventions (20 papers). Minh Lê is often cited by papers focused on HIV/AIDS drug development and treatment (33 papers), HIV Research and Treatment (23 papers) and HIV/AIDS Research and Interventions (20 papers). Minh Lê collaborates with scholars based in France, United States and Democratic Republic of the Congo. Minh Lê's co-authors include Gilles Peytavin, Diane Descamps, Yazdan Yazdanpanah, Charlotte Charpentier, Aude Desnoyer, Laurent Massias, Laurent Mandelbrot, Anne‐Geneviève Marcelin, Alexandra Heurgué–Berlot and Vincent Cálvez and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Minh Lê

49 papers receiving 635 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Minh Lê France	14	402	217	186	140	92	53	644
Silvia Cohn United States	12	409 1.0×	336 1.5×	38 0.2×	28 0.2×	71 0.8×	22	551
Pavel Khaykin Germany	10	226 0.6×	249 1.1×	195 1.0×	73 0.5×	16 0.2×	30	530
Paola Cicconi Italy	17	489 1.2×	351 1.6×	369 2.0×	130 0.9×	28 0.3×	45	881
Barbara Menzaghi Italy	16	316 0.8×	115 0.5×	180 1.0×	44 0.3×	24 0.3×	46	534
Nomathemba Chandiwana South Africa	9	474 1.2×	105 0.5×	248 1.3×	27 0.2×	22 0.2×	26	628
P. D’Argenio Italy	9	280 0.7×	133 0.6×	155 0.8×	15 0.1×	32 0.3×	13	498
Simiso Sokhela South Africa	12	606 1.5×	132 0.6×	326 1.8×	29 0.2×	20 0.2×	31	791
Manuel Crespo Spain	15	207 0.5×	264 1.2×	151 0.8×	260 1.9×	35 0.4×	47	776
Frank Tomaka United States	12	653 1.6×	133 0.6×	446 2.4×	80 0.6×	15 0.2×	24	713
Marcel Stoeckle Switzerland	14	336 0.8×	169 0.8×	152 0.8×	49 0.3×	45 0.5×	54	517

Countries citing papers authored by Minh Lê

Since Specialization

Citations

This map shows the geographic impact of Minh Lê's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minh Lê with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minh Lê more than expected).

Fields of papers citing papers by Minh Lê

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minh Lê. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minh Lê. The network helps show where Minh Lê may publish in the future.

Co-authorship network of co-authors of Minh Lê

This figure shows the co-authorship network connecting the top 25 collaborators of Minh Lê. A scholar is included among the top collaborators of Minh Lê based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minh Lê. Minh Lê is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Timsit, Jean‐François, et al.. (2025). Eravacycline as a last resort for difficult-to-treat resistant Acinetobacter baumannii infections in critically ill patients: three case reports with pharmacokinetic insights. JAC-Antimicrobial Resistance. 7(3). dlaf095–dlaf095.

Kably, Benjamin, Mathilde Briard, Claire Francoz, et al.. (2025). Population pharmacokinetics of aciclovir and its major metabolite 9-carboxymethoxymethylguanine and safety profile of valaciclovir in early liver transplant recipients. Journal of Antimicrobial Chemotherapy. 80(5). 1302–1308. 1 indexed citations

Lê, Minh, Clotilde Allavena, Véronique Joly, et al.. (2025). Switch to bictegravir/emtricitabine/tenofovir alafenamide in people living with HIV aged 65 years or older: BICOLDER study – IMEA 057. Journal of Infection and Public Health. 18(11). 102946–102946.

Wicky, Paul-Henri, M.A. Alves, Juliette Patrier, et al.. (2023). Cefiderocol Treatment for Severe Infections due to Difficult-to-Treat-Resistant Non-Fermentative Gram-Negative Bacilli in ICU Patients: A Case Series and Narrative Literature Review. Antibiotics. 12(6). 991–991. 17 indexed citations

Tantet, Claire, Chakib Alloui, F. Méchaï, et al.. (2023). HIV-1 infection in South Kivu (Democratic Republic of Congo): high genotypic resistance to antiretrovirals. Journal of Antimicrobial Chemotherapy. 78(7). 1732–1739. 4 indexed citations

Ferré, Valentine Marie, Gilles Peytavin, Minh Lê, et al.. (2023). Pharmaco‐virological algorithm to target risk of drug resistance among a population of HIV‐infected key populations in Togo. Journal of Medical Virology. 95(2). e28535–e28535. 2 indexed citations

Lemaı̂tre, F., Marie‐Claude Gagnieu, François Parant, et al.. (2023). Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV‐1‐infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS‐MIE‐BIRIDER study). British Journal of Clinical Pharmacology. 90(1). 264–273.

Palich, Romain, Basma Abdi, Marc Wirden, et al.. (2021). Intermittent two-drug antiretroviral therapies maintain long-term viral suppression in real life in highly experienced HIV-infected patients. Journal of Antimicrobial Chemotherapy. 76(7). 1893–1897. 1 indexed citations

Ghosn, Jade, Lambert Assoumou, Caroline Lascoux‐Combe, et al.. (2021). HIV-1 RNA Kinetics in Blood Plasma and in Seminal Plasma of Men Starting a Dolutegravir-Based Triple-Combination Regimen at the Time of Primary HIV-1 Infection. The Journal of Infectious Diseases. 225(1). 116–120. 4 indexed citations

10.

Lê, Minh, Naïm Bouazza, Florence Gattacceca, et al.. (2020). Usefulness of therapeutic drug monitoring of rilpivirine and its relationship with virologic response and resistance in a cohort of naive and pretreated HIV‐infected patients. British Journal of Clinical Pharmacology. 86(12). 2404–2413. 9 indexed citations

11.

Lê, Minh, Pierre Jaquet, Juliette Patrier, et al.. (2020). Pharmacokinetics of lopinavir/ritonavir oral solution to treat COVID-19 in mechanically ventilated ICU patients. Journal of Antimicrobial Chemotherapy. 75(9). 2657–2660. 11 indexed citations

12.

Lê, Minh, Quentin Le Hingrat, Pierre Jaquet, et al.. (2020). Removal of Remdesivir’s Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19. Antimicrobial Agents and Chemotherapy. 64(11). 16 indexed citations

13.

Peytavin, Gilles, Minh Lê, Lionel Carbillon, et al.. (2020). Frequency of differential placental transfer to twins of maternal antiretroviral medications. European Journal of Obstetrics & Gynecology and Reproductive Biology. 256. 405–411. 1 indexed citations

14.

Faure‐Bardon, Valentine, Gilles Peytavin, Minh Lê, et al.. (2020). Placental transfer of Letermovir & Maribavir in the ex vivo human cotyledon perfusion model. New perspectives for in utero treatment of congenital cytomegalovirus infection. PLoS ONE. 15(4). e0232140–e0232140. 15 indexed citations

15.

Vindrios, William, Nicolas Argy, Solène Le Gal, et al.. (2017). Outbreak of Pneumocystis jirovecii Infection Among Heart Transplant Recipients: Molecular Investigation and Management of an Interhuman Transmission. Clinical Infectious Diseases. 65(7). 1120–1126. 29 indexed citations

16.

Seang, Sophie, Thuy Nguyen, Minh Lê, et al.. (2017). Darunavir/ritonavir monotherapy at a low dose (600/100 mg/day) in HIV-1-infected individuals with suppressed HIV viraemia. Journal of Antimicrobial Chemotherapy. 73(2). 490–493. 5 indexed citations

17.

Perrier, Marine, Charlotte Charpentier, Gilles Peytavin, et al.. (2017). Switch as maintenance to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate: week 48 results in a clinical cohort. Journal of Antimicrobial Chemotherapy. 72(6). 1745–1751. 7 indexed citations

18.

Bocket, Laurence, Gilles Peytavin, Enagnon Kazali Alidjinou, et al.. (2016). Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patients. Journal of Antimicrobial Chemotherapy. 71(9). 2651–2653. 4 indexed citations

19.

Truchis, Pierre de, Minh Lê, Eric Adéhossi, et al.. (2016). High efficacy of first-line ART in a West African cohort, assessed by dried blood spot virological and pharmacological measurements. Journal of Antimicrobial Chemotherapy. 71(11). 3222–3227. 7 indexed citations

20.

Charpentier, Charlotte, Minh Lê, Véronique Joly, et al.. (2015). Use of PCR Signal and Therapeutic Drug Monitoring in a Switch Cohort Study to Tenofovir/Emtricitabine/Rilpivirine: A W96 Follow-Up. PLoS ONE. 10(7). e0134430–e0134430. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact